Both in Pharmaceuticals
Xencor vs Palvella Therapeutics
Over the past year XNCR returned +99.1% and PVLA returned +101.6%; their daily moves had a correlation of 0.33.
XNCR +99.1% PVLA +101.6%Growth of $1, one year, split-adjusted
| Metric | XNCR | PVLA |
|---|---|---|
| Price | $29.21 | $151.58 |
| Market cap | $2.17B | $2.18B |
| Today | −2.60% | +2.79% |
| 1 month | +17.1% | +9.9% |
| 6 months | +144.8% | +18.1% |
| Year to date | +90.8% | +44.8% |
| 1 year | +105.0% | +106.2% |
| Revenue growth (YoY) | +17.5% | — |
| Gross margin | 100.0% | — |
| Net margin | −42.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 20.7× | — |
| Net cash | $351.6M | $250.6M |
| Dividend yield | — | — |
| Volatility (60d) | 62.4% | 46.4% |
| Short % of float | 17.0% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).